Case Study: AstraZeneca and Vanguard Renewables U.S. RNG Agreement

This case study details the groundbreaking renewable natural gas (RNG) agreement between RTC Member AstraZeneca, a global biopharmaceutical company, and RTC Solutions Provider Vanguard Renewables. It provides an in-depth look at one of the largest business-to-business RNG purchases in the North American voluntary market, which will supply AstraZeneca with 650,000 MMBtu/year for 15+ years and contribute to the company’s ambition to reduce greenhouse gas emissions from its global operations (Scope 1 and 2) by 98% by 2026. Vanguard Renewables will build three new on-farm anaerobic digesters to produce the RNG.

Read this case study to understand the project’s origins, the decision-making process, and the collaborative efforts that led to its success. The case study offers valuable insights for others seeking to decarbonize their operations with renewable thermal solutions, especially RNG.

Fill out the form below to download the case study.
Related Materials: